Company Endocenter Srl with Fiscal Code 13863151
recorded a turnover of 2024 of
39.381,
with a net profit of
13.163
and having an average number of employees of
- .
The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Endocenter Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
55.922
69.998
66.288
60.265
72.288
68.580
68.636
70.056
34.416
39.381
Total Income - EUR
55.923
72.449
66.288
67.189
72.475
70.834
85.090
73.300
34.417
53.067
Total Expenses - EUR
48.384
70.294
66.347
63.821
67.652
71.240
69.982
64.281
12.757
35.079
Gross Profit/Loss - EUR
7.539
2.154
-59
3.368
4.823
-406
15.108
9.019
21.659
17.988
Net Profit/Loss - EUR
6.333
1.556
-1.335
2.696
4.098
-1.093
14.272
8.031
18.151
13.163
Employees
3
4
7
4
4
4
2
1
0
0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 15.1%, from 34.416 euro in the year 2023, to 39.381 euro in 2024.
The Net Profit decreased by -4.886 euro, from 18.151 euro in 2023, to 13.163 in the last year.
Check the financial reports for the company - Endocenter Srl
Financial Rating - ENDOCENTER SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Endocenter Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Endocenter Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Endocenter Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
39.197 euro in 2024 which includes Inventories of
0 euro, Receivables of
0 euro and cash availability of
37.187 euro.
The company's Equity was valued at
43.120 euro, while total Liabilities amounted to
24.517 euro.
Equity increased by 13.163 euro, from 30.125 euro in 2023, to 43.120 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Endocenter Srl